2026 ASTRO Hub

(Left to right) PGY-2 residents Dr. Luiza Giuliani Schmitt and Dr. Boya Wang review cases with Department Chair Dr. Simon Powell.
(Left to right) PGY-2 residents Dr. Luiza Giuliani Schmitt and Dr. Boya Wang review cases with Department Chair Dr. Simon Powell.
Associate Program Director, Dr. Brandon Imber, supervises PGY-3 resident, Dr. Joshua Qian, during a physical examination as part of a patient’s clinical evaluation.
Associate Program Director, Dr. Brandon Imber, supervises PGY-3 resident, Dr. Joshua Qian, during a physical examination as part of a patient’s clinical evaluation.
Dedicated to mentorship: Program Director Dr. Daniel Gorovets provides individualized guidance to support trainee growth and clinical excellence.
Dedicated to mentorship: Program Director Dr. Daniel Gorovets provides individualized guidance to support trainee growth and clinical excellence.
Dedicated clinical training: Attending physician and Associate Program Director Dr. Diana Roth O'Brien mentors PGY-4 resident Dr. Revathi Ravella.
Dedicated clinical training: Attending physician and Associate Program Director Dr. Diana Roth O'Brien mentors PGY-4 resident Dr. Revathi Ravella.

Welcome to the 2026 ASTRO Hub

Connect with our team and explore our research, educational sessions, and networking events throughout the annual meeting. Below, you will find our complete schedule of faculty and resident presentations, specialized sessions exploring the latest AI advancements in radiation oncology, and our dedicated Holman Pathway Q&A session. If you are an aspiring trainee or prospective applicant, we invite you to join our residency leadership for our Program Director Coffee Hour and Donuts with Medical Students to learn firsthand about our culture and training opportunities.

Special Events & Meetups
Booth #2840 Thomas M. Menino Convention Center
 

flyer for coffee and networking with Rad Onc program directors
Monday, Sept 28
Coffee & Donuts with the PD
πŸ•’ Time: –
🎯 Focus: Prospective medical students and residency applicants; meet program leadership, ask questions, and learn about our training culture.

Fellowship Opportunities Q&A
πŸ•’ Time: –
🎯 Focus: Prospective clinical fellows; specialized clinical tracks, research integration, and ABS β€œ300 in 10” brachytherapy training.

Tuesday, Sept 29
AI Advancement in Rad/Onc
πŸ•’ Time: –
🎯 Focus: Machine learning applications, auto-contouring tools, and clinical integration for trainees, clinicians, and researchers.

Holman Research Pathway Q&A
πŸ•’ Time: –
🎯 Focus: Prospective physician-scientist applicants; 18 months of intensive protected research, mentorship pipelines, and project design.

Faculty presentations

Explore the cutting-edge clinical research, scientific breakthroughs, and educational contributions led by our faculty at ASTRO 2026. From advances in AI-driven modeling and adaptive radiation therapy to clinical trial outcomes and technological innovations across disease sites, our faculty are shaping the future of oncology care. Browse the full schedule below to find session dates, presentation times, and room locations.

Scroll right to see all information

DateTimeSession #/TitlePresentation TitlePresenter/RoleRoom
9/26/2026Workshop 01 – Physics Insights for Advanced Clinical Practice: Adaptive, Re-irradiation, AI and TrialsAdvanced Technologies in Clinical Trials: Physics Partnership in Technology-driven Radiotherapy Clinical TrialsChuck Simone β€” Speaker204
9/27/20263:00– ETSS 03 – Technologically Driven Strategies in HPV-related OPSCCPooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer Demonstrating Reduced Toxicity with Durable Long-Term ControlNancy Lee β€” Speaker162
9/27/20264:00– ETDigital PosterQuantitative Dosimetric Analysis Of Patterns Of Local Recurrence (LR) After IMRT For Primary Undifferentiated Pleomorphic Sarcoma (UPS) of the ExtremityBoris Muller 
9/28/20268:00– ET (block); talk 8:15–QP 06 – Neurocognition and Novel Therapies in GliomaPilot Study of Tumor Treating Fields for Brainstem GliomasJames Janopaul-Naylor β€” Speaker254
9/28/20268:00– ET (block); talk 8:30–QP 05 – Predicting Outcomes in Breast Cancer: From Multi-Omics to AI-Driven ModelsValidated Nomogram Tool Predicting Individualized Risks of Invasive Disease Recurrence for Breast Cancer Patients with N1mic Treated with and without Nodal RadiotherapyGeorge Naoum β€” Speaker258
9/28/2026SS12 – Small Cell Lung Cancer and Thymic Malignancy Chuck Simone β€” Discussant157
9/28/202610:45 AM– ETPQA 03 – Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer BiologyAI-Based Thoracic OAR Auto-Segmentation to Quantify Volumetric Differences Between 3D-CRT and IMRT in Whole-Breast Radiotherapy After Oncoplastic ReductionTaran Singh (presenting for Quincey LaPlant) 
9/28/202610:45 AM– ETPQA 03 – Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer BiologyDevelopment and Multi-Physician Validation of AI-Based Segmentation of Breast CTV and Tangent Field Geometry In Whole-Breast RadiotherapyTaran Singh (presenting for Quincey LaPlant) 
9/28/202610:45 AM– ET (block); talk 11:07–EDU 18 – Integrating Postmastectomy Radiotherapy (PMRT) with Breast Reconstruction: Insights from Plastic Reconstructive Surgery and the Role of the Radiation OncologistPostmastectomy Radiation Techniques and Planning Considerations with Breast ReconstructionGeorge Naoum β€” Speaker258
9/28/202610:45 AM– ET (block); talk 11:25–SS 22 – Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic MalignanciesPatterns of Progression after BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Lesion-Level PET/CT AnalysisAlexandra Dreyfuss β€” Speaker259
9/28/202610:45 AM– ET (block); talk 11:35–SS 22 – Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic MalignanciesBridging Radiotherapy Reduces Systemic Inflammation Prior to CAR T-Cell Therapy for B-Cell LymphomasBrandon Imber β€” Speaker259
9/28/20263:00– ETSS 24 – Innovations in Rare Cutaneous and Soft Tissue Malignancies Christopher Barker β€” Moderator205
9/28/20263:00– ET (block); segments 3:00– & 3:47–EDU 30 – Reinvigorating and Expanding the Role for Radiotherapy for Hematological Malignancies of the Central Nervous SystemIntroductions; Questions and AnswersBrandon Imber β€” Moderator/Speaker257
9/28/20263:00– ETPQA 04 – Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global OncologyWhole Brain Radiotherapy Achieves Durable Control in Methotrexate-Refractory Primary CNS LymphomaShayla Murray, BS (Brandon Imber’s student)Poster Hall – Exhibit Hall A
9/28/20265:02– ETEDU 35 – Biological Insights into Selection of Specific HPV+ Oropharyngeal Cancer Patients Appropriate for Radiation Dose De-escalationHypoxia Directed Treatment of Human Papillomavirus-Related Oropharyngeal CarcinomaNadeem Riaz β€” Speaker160
9/29/20262:15– ETPQA 06 – Genitourinary Cancer, Gynecological Cancer, and Health Care Access and EngagementPreoperative Biopsy Genomic Classifier Predicts Earlier Secondary Radiotherapy after Radical Prostatectomy: National Real-World EvidenceThomas Kole β€” SpeakerPoster Hall – Exhibit Hall A
9/29/20262:15– ETPQA 06 – Genitourinary Cancer, Gynecological Cancer, and Health Care Access and EngagementAssociation of 22-Gene Genomic Classifier with ADT Use with Secondary Radiotherapy: A National Real-World AnalysisAndrew Barsky β€” SpeakerPoster Hall – Exhibit Hall A
9/29/20262:15– ETPQA 06 – Genitourinary Cancer, Gynecological Cancer, and Health Care Access and EngagementClinical vs. MRI Risk Signals In Intermediate-Risk Prostate Cancer Treated with Radiotherapy: Associations with PSA Density and Radiographic ECE/SVIJames Janopaul-Naylor β€” SpeakerPoster Hall – Exhibit Hall A
9/29/20262:15– ETPQA 06 – Genitourinary Cancer, Gynecological Cancer, and Health Care Access and EngagementSafety of Spine Radiotherapy Delivered within 6 Months of Lu-177 PSMA Radioligand Therapy in Metastatic Prostate CancerJoshua Qian β€” SpeakerPoster Hall – Exhibit Hall A
9/29/20262:15– ETPQA 06 – Genitourinary Cancer, Gynecological Cancer, and Health Care Access and EngagementLifetime Risk of Androgen Deprivation Therapy after Active Surveillance for Prostate CancerJames Janopaul-Naylor β€” SpeakerPoster Hall – Exhibit Hall A
9/29/20263:45– ETPQA 07 – Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive CareExploratory Outcomes from a Phase II ctDNA-Guided Consolidation Trial in KRAS G12C-Mutant Locally Advanced NSCLCNikhil Mankuzhy β€” PresenterPoster Hall – Exhibit Hall A
9/29/202612:30– ET (block); talk 12:52–EDU 42 – Radiation Wins: New Evidence and Evolving Strategies in Multiple MyelomaStrategic Integration of RT in Multiple MyelomaAlexandra Dreyfuss β€” Speaker204
9/29/20265:15– ET (block); talk 5:35–QP 28 – Actionable Biomarkers: Guiding Therapy Selection and De-escalationReal-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored PatientsThomas Kole β€” Speaker205
9/29/20265:20– ET Excellent 2- and 3-Year OS after Ablative MRgRT for Localized Pancreatic Cancer without SurgeryMarsha Reyngold β€” Presenter259
9/30/20269:15– ETSS 47 – Spine SBRT: Risk, Safety, and Outcomes Yoshiya Yamada β€” Discussant160
9/30/2026SH09 – Lung Cancer/Thoracic Malignancies – Science Highlights Chuck Simone β€” Moderator162
9/30/20269:15– ET (block); talk 9:45–SS 46 – Right-Sizing Radiation in Early Breast Cancer: Omission, Shortening, and Targeted ApproachesHER2-Low as an Independent Prognostic Entity in Node-Negative Early Breast Cancer: Implications for Classification and Adjuvant Treatment/Radiation De-EscalationGeorge Naoum β€” Speaker258
9/30/202610:30– ETQP 43 – Treatment Strategies in Localized and Advanced Prostate CancerElective Pelvic Nodal Radiation in Prostate Cancer with and without Mesorectal or Extra-Pelvic DiseaseJade Dodge 

Resident Presentations

Discover the next generation of leaders in radiation oncology by exploring the groundbreaking research presented by our resident physicians. Spanning innovative translational science, machine learning models, ctDNA biomarkers, and advanced treatment techniques across multiple disease sites, their work exemplifies our commitment to scientific inquiry and clinical excellence. Browse the schedule below to view session dates, times, and details for all resident oral presentations and scientific posters.

Scroll right to see all information

NamePGYTitlePoster/OralPI/sDateTime
Alok Deshane5Fast Forward: Hypofractionated, Dose De-escalated Radiotherapy for Multiple MyelomaQuick Pitch OralImber/Yahalom09/275:00–
Alok Deshane5Inpatient Radiation Oncology Consultations for Hematologic Malignancies: Indications, Management Patterns, and OutcomesPosterYerramilli/Imber09/283:00–
David Miller5Thymic Composition on CT Associates with Peripheral Immune Phenotype in Lung CancerPosterChaunzwa, Taf09/293:45–
David Miller5Disease-Free Interval as an Independent Predictor of Survival Following Ipsilateral Recurrence of Early-Stage Breast CancerPosterBraunstein, Lior09/283:00–
Helen Zhang5Patterns of Failure and Outcomes of Oligoprogression in ALK-Rearranged NSCLC Treated with ALK TKIsPosterIyengar, Puneeth09/293:45–
Helen Zhang5Comparative Analysis of Intratumoral Microbiomes in HPV-Associated Oropharyngeal and Cervical CancersPosterWilliams/Riaz09/293:45–
Kevin Boehm5Multimodal Modeling of Detailed Cancer Subtypes and Molecular Features from >60,000 Patients with Co-Registered H&E Images and Clinical Tumor SequencingOralShah, Schultz, Sanchez-Vega09/273:00–
Sybil Jones5Outcomes in Hospitalized Patients Evaluated for Palliative Radiation Therapy for Tumor-Related BleedingPosterYerramilli, Divya09/28
Elisa Liu4Circulating Tumor DNA Positivity after Chemoradiation Marks an Imminent High-Risk State in Anal Squamous Cell CarcinomaOralRomesser, Paul09/285:00–
Elisa Liu4Impact of von-Hippel Lindau Mutations on Local Control after Spine Stereotactic Body Radiation Therapy for Renal Cell CarcinomaOralJackson, Chris09/309:15–
Gideon Haber4Comparative Evaluation of 3D-CRT, VMAT, and PBS-PT for Bilateral Breast/Chest Wall and Regional Nodal IrradiationPosterChoi, Isabelle09/283:00–
Kathryn Hockemeyer4A Single Arm Phase II Study Assessing Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastasis (BM) from Small Cell Lung Cancer (SCLC)PosterPike, Luke09/273:00–
Revathi Ravella4Tumor-Informed Circulating Tumor DNA for Prediction of Organ Preservation and Enhanced Surveillance in Locally Advanced Rectal Cancer: A Real-World CohortOralRomesser, Paul09/288:00–
Revathi Ravella4Durability of Watch-and-Wait after Long- vs. Short-Course Radiation In Total Neoadjuvant Therapy for Rectal CancerOralRomesser, Paul09/288:00–
Shoshana Rosenzweig4Post-Hoc Subgroup Analysis of Patients with Breast Cancer Experiencing Polymetastatic Progression on CURB Oligoprogression TrialPosterXu, Amy09/283:00–
Ali Sabbagh3Beyond Traditional Models: Machine Learning Identification of Interaction Effects In ORNPosterLee, Nancy09/293:45–
Joshua Qian3Temporary Organ Displacement for Sacral Chordoma Stereotactic RadiosurgeryPosterYamada, Josh09/274:00–
Joshua Qian3Safety of Spine Radiotherapy Delivered within 6 Months of Lu-177 PSMA Radioligand Therapy in Metastatic Prostate CancerPosterImber, Gorovets09/292:15–
Drew Bergman3Biology-Guided Radiotherapy In Pan-HPV Head and Neck Cancer Using Genomic-Adjusted Radiation DoseOralScott, JG09/273:30–
Drew Bergman3Impact of Radioresistance and Radiosensitivity Gene Alterations on Locoregional Control after Proton Radiotherapy for NSCLCPosterβ€”09/293:45–
Mitchell Parker3Redefining the Limits of SRS for Brain Metastases: A Large Contemporary Cohort AnalysisPosterPike, Luke09/273:00–
Mitchell Parker3BrainMATTER: Brain Metastasis Auto-Tracking through Text Extraction from ReportsPosterPike, Luke09/2810:45 AM–